Beta-Blockers Safe in COPD With Cardiovascular Comorbidities
There was a trend toward a reduction in mortality in patients with COPD who received beta-blocker treatment compared with patients who did not.
There was a trend toward a reduction in mortality in patients with COPD who received beta-blocker treatment compared with patients who did not.
Vitamin C was associated with lower mortality rates, shorter lengths of ICU stay, and shorter durations of vasopressor use in patients with sepsis.
Vitamin D deficiency is associated with increased risk for sepsis mortality in postmenopausal women, which was seen in all ages.
Oral ciprofloxacin has been found to be an effective option for gram-negative bacteremia treatment.